Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians.

Wang, Minxian; Menon, Ramesh; Mishra, Sanghamitra; Patel, Aniruddh P; Chaffin, Mark; Tanneeru, Deepak; Deshmukh, Manjari; Mathew, Oshin et al. · J Am Coll Cardiol · 2020

case_control · Level III

Where this comes from

Abstract

Genome-wide polygenic scores (GPS) integrate information from many common DNA variants into a single number. Because rates of coronary artery disease (CAD) are substantially higher among South Asians, a GPS to identify high-risk individuals may be particularly useful in this population. This analysis used summary statistics from a prior genome-wide association study to derive a new GPS<sub>CAD</sub> for South Asians. This GPS<sub>CAD</sub> was validated in 7,244 South Asian UK Biobank participants and tested in 491 individuals from a case-control study in Bangladesh. Next, a static ancestry and GPS<sub>CAD</sub> reference distribution was built using whole-genome sequencing from 1,522 Indian individuals, and a framework was tested for projecting individuals onto this static ancestry and GPS<sub>CAD</sub> reference distribution using 1,800 CAD cases and 1,163 control subjects newly recruited in India. The GPS<sub>CAD</sub>, containing 6,630,150 common DNA variants, had an odds ratio (OR) per SD of 1.58 in South Asian UK Biobank participants and 1.60 in the Bangladeshi study (p < 0.001 for each). Next, individuals of the Indian case-control study were projected onto static reference distributions, observing an OR/SD of 1.66 (p < 0.001). Compared with the middle quintile, risk for CAD was most pronounced for those in the top 5% of the GPS<sub>CAD</sub> distribution-ORs of 4.16, 2.46, and 3.22 in the South Asian UK Biobank, Bangladeshi, and Indian studies, respectively (p < 0.05 for each). The new GPS<sub>CAD</sub> has been developed and tested using 3 distinct South Asian studies, and provides a generalizable framework for ancestry-specific GPS assessment.

Medical subject headings